Literature DB >> 7922227

Atherosclerosis in chronic renal failure.

D I Charney1, D F Walton, A K Cheung.   

Abstract

Atherosclerotic cardiovascular disease is a significant cause of morbidity and mortality in patients with chronic renal failure. It is unclear, however, if atherosclerosis in fact occurs at a higher incidence compared with the nonuremic population matched for age, hypertension, and diabetes mellitus or if it occurs at an accelerated rate following the onset of end-stage renal disease. The extent of true atherosclerotic lesions, versus clinically diagnosed "atherosclerosis," in patients with chronic renal failure is equally unclear. Potentially, the uremic state per se, the dialysis treatment, and factors unrelated to renal failure may participate in atherogenesis. The relative contribution of each of these factors is unknown. In this review, we discuss the pathology of "atherosclerotic" lesions in patients with chronic renal failure and the putative factors involved in atherogenesis in this population and describe the results of available studies examining the issue of accelerated atherosclerosis in uremia.

Entities:  

Mesh:

Year:  1993        PMID: 7922227     DOI: 10.1097/00041552-199311000-00004

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  6 in total

Review 1.  The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Expert Rev Mol Med       Date:  2009-03-12       Impact factor: 5.600

2.  Influence of diabetes on persistent nonhealing ischemic foot ulcer in end-stage renal disease.

Authors:  Hiroshi Yasuhara; Shuji Naka; Hironobu Yanagie; Hirokazu Nagawa
Journal:  World J Surg       Date:  2002-07-22       Impact factor: 3.352

3.  Role of advanced glycation end products in cardiovascular disease.

Authors:  Zeinab Hegab; Stephen Gibbons; Ludwig Neyses; Mamas A Mamas
Journal:  World J Cardiol       Date:  2012-04-26

Review 4.  The Diet and Haemodialysis Dyad: Three Eras, Four Open Questions and Four Paradoxes. A Narrative Review, Towards a Personalized, Patient-Centered Approach.

Authors:  Giorgina Barbara Piccoli; Maria Rita Moio; Antioco Fois; Andreea Sofronie; Lurlinys Gendrot; Gianfranca Cabiddu; Claudia D'Alessandro; Adamasco Cupisti
Journal:  Nutrients       Date:  2017-04-10       Impact factor: 5.717

Review 5.  From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling.

Authors:  Luis Vitetta; Anthony W Linnane; Glenda C Gobe
Journal:  Toxins (Basel)       Date:  2013-11-07       Impact factor: 4.546

Review 6.  Gut Microbiome and Kidney Disease in Pediatrics: Does Connection Exist?

Authors:  Tetyana L Vasylyeva; Ruchi Singh
Journal:  Front Microbiol       Date:  2016-03-03       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.